Evaluation of AZD8154 Concentrations in Blood

Summary

This study is intended to evaluate the systemic pharmacokinetic (PK) characteristics and the safety of AZD8154 following administration of the Monodose DPI formulation compared with the administration of the nebuliser suspension.

Timeline

Start

2020-07-17

Primary completion

2020-09-02

Completion

2020-09-02

Outcome

Outcome not reported

Stopped: “Need for evaluation of emerging pre-clinical toxicology findings”

Drugs

Indications